Department of Cellular Therapy,
Department of Oncology,
Department of Cellular Therapy, Department of Oncology
Else-Marit Inderberg has not added Biography.
If you are Else-Marit Inderberg and would like to personalize this page please email our Author Liaison for assistance.
Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancer.
Cancer immunology, immunotherapy : CII Jul, 2017 | Pubmed ID: 28391357
A TCR-based Chimeric Antigen Receptor.
Scientific reports Sep, 2017 | Pubmed ID: 28878363
Human c-SRC kinase (CSK) overexpression makes T cells dummy.
Cancer immunology, immunotherapy : CII Apr, 2018 | Pubmed ID: 29248956
Artesunate shows potent anti-tumor activity in B-cell lymphoma.
Journal of hematology & oncology Feb, 2018 | Pubmed ID: 29458389
Oslo University Hospital-Radiumhospitalet
Pierre Dillard1,
Hakan Köksal1,
Else-Marit Inderberg1,
Sebastien Wälchli1
1Department of Cellular Therapy, Department of Oncology, Oslo University Hospital-Radiumhospitalet
Конфиденциальность
Условия эксплуатации
Политика
СВЯЖИТЕСЬ С НАМИ
РЕКОМЕНДОВАТЬ БИБЛИОТЕКЕ
НОВОСТИ JoVE
Исследования
JoVE Journal
Подборки методов
JoVE Encyclopedia of Experiments
Архив
Образование
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Business
JoVE Quiz
JoVE Playlist
АВТОРЫ
Библиотекарь
Доступ
О JoVE
JoVE Sitemap
Авторские права © 2025 MyJoVE Corporation. Все права защищены